세계의 정맥주사액 시장 : 유형별, 영양소별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Intravenous Solutions Market, By Type, By Nutrients, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,574,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,544,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,952,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 하이라이트

정맥주사액(Intravenous Solutions) 시장 규모는 2022년에 119억 1,011만 달러로 평가되었으며, 2023년부터 2030년까지 CAGR 8.11%로 확대될 전망입니다.

의료 영역에서 정맥주사는 병원, 진료소, 응급실 등 다양한 의료 환경에서 중추적인 역할을 담당하고 있습니다. 적절한 체액 균형을 유지 및 조절하고, 중요한 생리적 과정을 지원하며, 치료 화합물과 영양소를 효율적으로 분배할 수 있는 능력에 그 중요성이 있습니다.

정맥주사액 시장 - 시장 역학 :

• 신경질환, 소화기질환, 암 등 질환발생률 증가
• 정맥주사액 시장의 강력한 확장은 위장 장애, 신경 질환 및 암을 포함한 다양한 의학적 질환의 급증하는 유병률에 기인할 수 있습니다. 이러한 질환은 효과적인 약물 투여와 수분 공급을 위해 정맥 요법을 사용해야 하는 경우가 많습니다. 따라서 환자에게 중요한 생명줄 역할을 하는 정맥주사액에 대한 수요가 눈에 띄게 증가하고 있습니다. 이러한 수요 증가는 환자 치료를 개선할 뿐만 아니라 의료 전문가들이 광범위한 의료 상태를 관리하기 위해 이러한 솔루션에 점점 더 의존함에 따라 시장 성장을 촉진하고 있습니다.
• 세계 보건 데이터에 따르면 세계보건기구(WHO)는 2018년 전 세계 암 발병률이 1,810만 건을 넘어섰으며 2034년에는 이 수치가 2,200만 건으로 급증할 것으로 예상하고 있습니다. 또한, WHO 통계에 따르면 미국에서는 약 6,000만-7,000만 명이 위장 질환을 앓고 있는 것으로 추정됩니다. 이러한 유병률은 포도당, 인지질, 글루타민, 아미노산을 포함하는 비경구 영양 솔루션이 환자의 건강 관리 요구 사항을 해결하기 위해 점점 더 많이 필요함을 강조합니다.

정맥주사액 시장-세분화 분석 :

세계의 정맥주사액 시장은 세 가지 주요 차원에서 세분화를 보여줍니다 : 유형, 영양소, 지역.

유형 분류 측면에서 시장은 완전 비경구와 말초 비경구로 분류 할 수 있습니다. 완전 비경구 영양은 소화 시스템을 우회하여 영양액을 혈류로 직접 전달하는 것을 포함합니다. 이러한 솔루션의 투여는 일반적으로 개인의 체중, 나이, 신장 및 특정 의학적 상태와 같은 요인에 따라 맞춤화됩니다. 이러한 솔루션은 위장 장애 관리, 화상 부상 치료, 장 증후군 해결, 화학 요법 중인 환자 지원, 수술 후 회복 촉진에 광범위하게 사용됩니다.

정맥주사액 시장-경쟁 구도 :

기업은 기업 웹사이트, 전자상거래 플랫폼, 소매 파트너, 유통업체, 소비자에게 직접 접근하는 등 여러 채널을 활용하여 제품을 시장에 출시하기 위해 다양한 전략을 채택하고 있습니다. 제품 제조사 간의 경쟁은 가격, 성능, 제조 공정, 기술 진보, 브랜드 명성, 제품 가용성 등 다양한 요인에 중점을 둡니다. 시장에서 존재감을 높이고 점유율을 확대하기 위해 기업은 다양한 전술을 사용합니다. 여기에는 신제품 소개, 유통망 확대, R&D 투자, M&A 등이 포함됩니다.

예를 들어, 2022년 2월, B. Braun Medical은 미국 식품의약국에서 플로리다 주 데이토나 비치에 신설한 주입용 생리 식염수 제조 시설의 조업 개시 허가를 취득했습니다. 또한 2021년 9월에 에어스탑 구성품(옵션)이 포함된 케어세이프 정맥주사 세트를 출시하여 제품 포트폴리오를 강화했습니다.

목차

제1장 정맥주사액 시장 개요

• 조사 범위
• 시장 추정 연도

제2장 주요 요약

• 시장 분석
• 경쟁 인사이트

제3장 정맥주사액-주요 시장 동향

• 시장 성장 촉진 요인
• 시장 성장 억제 요인
• 시장 기회
• 향후 시장 동향

제4장 정맥주사액-산업 연구 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 맵핑
• 규제 프레임워크 분석

제5장 정맥주사액 시장 : COVID-19 영향 분석

• COVID-19 이전 영향 분석
• COVID-19 이후 영향 분석

제6장 정맥주사액 시장 상황

• 정맥주사액 시장 점유율 분석(2022년)
• 주요 제조사별 분석 데이터
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 정맥주사액 시장-유형별

• 개요
  • 유형별 부문 점유율 분석
  • 완전 비경구
  • 말초 비경구

제8장 정맥내 용액 시장-영양소별

• 개요
  • 영양소별 부문 점유율 분석
  • 단일 투여 아미노산 용액
  • 탄수화물
  • 비경구 지질 에멀젼
  • 비타민과 미네랄
  • 기타

제9장 정맥주사액 시장-지역별

• 소개
• 북미
  • 개요
  • 북미의 주요 제조사
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조사
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아 태평양(APAC)
  • 개요
  • 아시아 태평양의 주요 제조사
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 남미
  • 개요
  • 남미의 주요 제조사
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조사
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제10장 주요 벤더 분석-정맥주사액 산업

• 경쟁 대시보드
• 기업 개요
  • Vifor Pharma Group
  • Vetter Pharma-Fertigung GmbH &Co. KG
  • Terumo Corporation
  • Smiths Medical(a division of Smiths Group plc)
  • Sippex Pharmaceuticals Pvt. Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • JW Pharmaceutical Corporation
  • ICU Medical, Inc.
  • Hospira(now part of Pfizer Inc.)
  • Grifols SA
  • Fresenius SE & Co. KGaA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Amanta Healthcare Ltd.

제11장 애널리스트의 전방위 전망

LYJ

영문 목차

영문목차

REPORT HIGHLIGHT

Intravenous Solutions Market size was valued at USD 11,910.11 Million in 2022, expanding at a CAGR of 8.11% from 2023 to 2030.

Intravenous infusion solutions, commonly referred to as IV infusions, are sterile liquid formulations administered directly into a patient's bloodstream through a needle or catheter. These specialized solutions are meticulously crafted to provide essential hydration, replenish vital electrolytes, and facilitate the delivery of medications or essential nutrients when a patient cannot ingest them orally.

Within the realm of healthcare, IV infusions play a pivotal role across various medical settings, encompassing hospitals, medical clinics, and emergency care units. Their significance lies in their ability to uphold and regulate proper fluid balance, support crucial physiological processes, and ensure the efficient dispensation of therapeutic compounds and nutrients.

Intravenous Solutions Market - Market Dynamics:

• Increasing incidence of diseases like neurological conditions, gastrointestinal disorders, and cancer

• The robust expansion of the Intravenous Solutions market can be attributed to the surging prevalence of various medical conditions, including gastrointestinal disorders, neurological ailments, and cancer. These conditions often necessitate the use of intravenous therapy for effective medication administration and hydration. Consequently, there has been a notable escalation in the demand for intravenous solutions, which serve as a crucial lifeline for patients. This heightened demand not only improves patient care but also fuels market growth, as healthcare professionals increasingly rely on these solutions to manage a wide spectrum of medical conditions.

• In line with global health data, the World Health Organization (WHO) reported that the global incidence of cancer exceeded 18.1 million cases in 2018, and this figure is projected to surge to 22.0 million by 2034. Furthermore, WHO statistics indicate that gastrointestinal diseases affect an estimated 60 to 70 million individuals in the United States. This prevalence underscores the growing need for parenteral nutritional solutions, encompassing glucose, phospholipids, glutamine, and amino acids, to address the healthcare requirements of patients.

Intravenous Solutions Market - Key Insights:

• According to insights provided by our research analysts, the global Intravenous Solutions market is anticipated to experience robust annual growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 7.9% during the forecast period spanning from 2023 to 2030.

• This industry's growth trajectory is underpinned by significant factors, primarily the escalating prevalence of various medical conditions such as neurological disorders, gastrointestinal ailments, and cancer.

• In terms of product categorization, the segment dedicated to total parenteral nutrition emerged as the leading contributor to market share for the year 2022.

• Furthermore, when considering nutrient segmentation, the single-dose amino acid category demonstrated its prominence in 2022.

• Geographically, North America emerged as the primary revenue-generating region for the market in the year 2022.

Intravenous Solutions Market- Segmentation Analysis:

• The worldwide Intravenous Solutions Market exhibits segmentation across three key dimensions: Type, Nutrient, and Geographic Region.

• In terms of Type classification, the market can be categorized into Total Parenteral Nutrition and Peripheral Parenteral Nutrition. Total Parenteral Nutrition involves the direct delivery of nourishing fluids into the bloodstream, bypassing the digestive system. The administration of these solutions is typically customized based on factors such as an individual's weight, age, height, and specific medical condition. These solutions find extensive use in the management of gastrointestinal disorders, treatment of burn injuries, addressing bowel syndromes, supporting patients undergoing chemotherapy, and facilitating post-surgical recovery.

Intravenous Solutions Market- Competitive Landscape:

Businesses employ a diverse array of strategies to bring their products to market, leveraging multiple channels like corporate websites, e-commerce platforms, retail partners, distributors, and direct-to-consumer approaches. Competition among product manufacturers centers on various factors encompassing pricing, performance, manufacturing processes, technological advancements, brand reputation, and product availability. To fortify their market presence and broaden their share, companies employ a range of tactics. These include the introduction of new products, the expansion of distribution networks, significant investments in research and development, and engaging in mergers and acquisitions.

For example, in February 2022, B. Braun Medical secured approval from the US Food and Drug Administration to initiate operations at their newly established IV saline solution production facility in Daytona Beach, Florida. In a separate instance from September 2021, B. Braun Medical Inc. unveiled CARESAFE IV Administration Sets, featuring an optional AirStop component, enhancing their product portfolio.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRAVENOUS SOLUTIONS MARKET KEY PLAYERS

• Vifor Pharma Group
• Vetter Pharma-Fertigung GmbH & Co. KG
• Terumo Corporation
• Smiths Medical (a division of Smiths Group plc)
• Sippex Pharmaceuticals Pvt. Ltd.
• Sichuan Kelun Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical Co., Ltd.
• JW Pharmaceutical Corporation
• ICU Medical, Inc.
• Hospira (now part of Pfizer Inc.)
• Grifols S.A.
• Fresenius SE & Co. KGaA
• Baxter International Inc.
• B. Braun Melsungen AG
• Amanta Healthcare Ltd.

GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY TYPE

• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY NUTRIENT

• Single-Dose Amino Acid Solutions
• Carbohydrates
• Parenteral Lipid Emulsion
• Vitamins & Minerals
• Others

GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY REGION

• North America
  • The U.S.
  • Canada

• Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe

• Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC

• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

• The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Intravenous Solutions Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Intravenous Solutions Market Snippet by Type
  • 2.1.2. Intravenous Solutions Market Snippet by Nutrient
  • 2.1.3. Intravenous Solutions Market Snippet by Country
  • 2.1.4. Intravenous Solutions Market Snippet by Region
• 2.2. Competitive Insights

3. Intravenous Solutions Key Market Trends

• 3.1. Intravenous Solutions Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Intravenous Solutions Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Intravenous Solutions Market Opportunities
• 3.4. Intravenous Solutions Market Future Trends

4. Intravenous Solutions Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Intravenous Solutions Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Intravenous Solutions Market Landscape

• 6.1. Intravenous Solutions Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Intravenous Solutions Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
  • 7.1.2. Total Parenteral Nutrition
  • 7.1.3. Peripheral Parenteral Nutrition

8. Intravenous Solutions Market - By Nutrient

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Nutrient, 2022 & 2030 (%)
  • 8.1.2. Single-Dose Amino Acid Solutions
  • 8.1.3. Carbohydrates
  • 8.1.4. Parenteral Lipid Emulsion
  • 8.1.5. Vitamins & Minerals
  • 8.1.6. Others

9. Intravenous Solutions Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. Intravenous Solutions Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. Intravenous Solutions Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.3.7. Italy
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.7.4. Italy Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.3.8. United Kingdom
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.8.4. United Kingdom Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.3.9. France
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.9.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.9.4. France Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.3.10. Russia
    • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.10.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.10.3. Russia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.3.11. Netherlands
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.11.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.11.3. Netherlands Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.3.12. Sweden
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.12.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.12.3. Sweden Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.3.13. Poland
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.13.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.13.3. Poland Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.3.14. Rest of Europe
    • 9.3.14.1. Overview
    • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. Intravenous Solutions Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.4.8. Japan
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.8.4. Japan Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.4.9. South Korea
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.9.4. South Korea Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. Intravenous Solutions Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. Intravenous Solutions Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Intravenous Solutions Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. Vifor Pharma Group
  • 10.2.2. Vetter Pharma-Fertigung GmbH & Co. KG
  • 10.2.3. Terumo Corporation
  • 10.2.4. Smiths Medical (a division of Smiths Group plc)
  • 10.2.5. Sippex Pharmaceuticals Pvt. Ltd.
  • 10.2.6. Sichuan Kelun Pharmaceutical Co., Ltd.
  • 10.2.7. Otsuka Pharmaceutical Co., Ltd.
  • 10.2.8. JW Pharmaceutical Corporation
  • 10.2.9. ICU Medical, Inc.
  • 10.2.10. Hospira (now part of Pfizer Inc.)
  • 10.2.11. Grifols S.A.
  • 10.2.12. Fresenius SE & Co. KGaA
  • 10.2.13. Baxter International Inc.
  • 10.2.14. B. Braun Melsungen AG
  • 10.2.15. Amanta Healthcare Ltd.

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us

관련자료